Release of hyaluronate from eukaryotic cells.
The mechanism of hyaluronate shedding from eukaryotic cell lines was analysed. All cell lines shed identical sizes of hyaluronate as were retained on the surface. They differed in the amount of hyaluronate synthesized and in the proportions of hyaluronate which were released and retained. A method was developed which could discriminate between shedding due to intramolecular degradation and that due to dissociation as intact macromolecules. This method was applied to B6 and SV3T3 cells in order to study the mechanism of hyaluronate release in more detail. The cells were pulse-labelled to form hyaluronate chains with labelled and unlabelled segments, and the sizes of labelled hyaluronate released into the medium during the pulse extension period were determined by gel filtration. B6 cells released identical sizes of hyaluronate at all labelled segment lengths, indicating that no intramolecular degradation occurred. When chain elongation was blocked by periodate-oxidized UDP-glucuronic acid, hyaluronate release was simultaneously inhibited. These results indicated that B6 cells dissociated hyaluronate as an intact macromolecule. In contrast, SV3T3 cells released hyaluronate of varying molecular mass distributions during extension of the labelled segment, suggesting partial degradation. Exogenous hyaluronate added to SV3T3 cultures was also degraded. This degradation could be prevented by the presence of radical scavengers such as superoxide dismutase and tocopherol. Degradation of endogenous hyaluronate could be inhibited by salicylate. These results led to the conclusion that SV3T3 cells released hyaluronate not only by dissociation, but also by radical-induced degradation.
Prehm
P
P
Institut für Physiologische Chemie und Pathobiochemie, Münster, Federal Republic of Germany.
D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D002477:Cells / Q000378:metabolism*; D005057:Eukaryotic Cells / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism; D005354:Fibrosarcoma; D005609:Free Radicals; D005944:Glucosamine / Q000378:metabolism; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism*; D006821:Hyaluronoglucosaminidase / Q000378:metabolism; D007700:Kinetics; D008970:Molecular Weight; D010084:Oxidation-Reduction; D010504:Periodic Acid; D012459:Salicylates / Q000494:pharmacology; D020156:Salicylic Acid; D013482:Superoxide Dismutase / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014535:Uridine Diphosphate Glucuronic Acid / Q000494:pharmacology; D014810:Vitamin E / Q000494:pharmacology
D005609:Free Radicals; D012459:Salicylates; D010504:Periodic Acid; D014810:Vitamin E; D014535:Uridine Diphosphate Glucuronic Acid; D006820:Hyaluronic Acid; D013482:Superoxide Dismutase; D006821:Hyaluronoglucosaminidase; D005944:Glucosamine; D020156:Salicylic Acid